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Abstract
Psoriasis is a common inflammatory skin disease with genetic components of both immune system and the epidermis.
PSOR1 locus (6q21) has been strongly associated with psoriasis; however, it is difficult to identify additional independent
association due to strong linkage disequilibrium in the MHC region. We performed stepwise regression analyses of more
than 3,000 SNPs in the MHC region genotyped using Human 610-Quad (Illumina) in 1,139 cases with psoriasis and 1,132
controls of Han Chinese population to search for additional independent association. With four regression models obtained,
two SNPs rs9468925 in HLA-C/HLA-B and rs2858881 in HLA-DQA2 were repeatedly selected in all models, suggesting that
multiple loci outside PSOR1 locus were associated with psoriasis. More importantly we find that rs9468925 in HLA-C/HLA-B is
associated with both psoriasis and vitiligo, providing first important evidence that two major skin diseases share a common
genetic locus in the MHC, and a basis for elucidating the molecular mechanism of skin disorders.
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Introduction
Psoriasis [MIM#177900] is a T cell-mediated inflammatory
skin disease, characterized by epidermal hyperproliferation and
dermal inflammation [1,2]. It affects 2–3% of people in the
European ancestry population [1], while 0.123% of individuals in
the Asian population [3]. Although some advances have recently
been made in elucidating the molecular mechanism of psoriasis, its
pathogenic mechanism is not completely understood. It is believed
that psoriasis has a strong genetic basis, and environmental factor
may trigger the initiation of the disease [4].
Over past years, certain efforts have been made to study the
genetic basis of psoriasis. Genome-wide linkage analyses have
identified nine susceptibility loci (PSORS1–9), only one locus has
been consistently replicated. A meta-analysis of multiple genome-
wide scans reveals genetic linkage to the major histocompatibility
complex (MHC) on chromosome 6p21 that includes the PSORS1
locus, which spans an approximate 220-kb segment on 6p21.3 [5].
The PSORS1 locus is likely to account for about 30% to 50% of
the heritability of the disease [6,7,8], and has been believed to be
the major genetic determinant of psoriasis [9].
The MHC locus is one of the most extensively studied regions in
the human genome. Large-scale genetic association studies have
identified multiple genetic variants at this locus contributed to risk
of a cluster of genetically complex diseases including multiple
sclerosis (MS), Type 1 diabetes (T1D), systemic lupus erythema-
tosus (SLE), ulcerative colitis (UC), Crohn’s disease (CD), and
rheumatoid arthritis (RA) [10]. Recent studies show that MHC
loci are likely to play some important roles in psoriasis and vitiligo
[11,12,13,14]. The classical MHC locus encompasses approxi-
mately 3.6 megabase pairs (Mb) on 6p21.3 and is divided into
three subregions: the telomeric class I, class III, and the
centromeric class II regions. It has been recently established by
the evidence that both linkage disequilibrium (LD) and MHC-
related genes exist outside the classically defined locus [15].
Genome-wide association study (GWAS) demonstrates that
SNPs in the MHC region are strongly associated with psoriasis in
different populations [11,14]. Several SNPs are associated with
psoriasis, but it is still unknown how many independent SNPs
located within the MHC region contribute to the risk of psoriasis.
The development of psoriasis is believed to involve a major locus
PSOR1 in the MHC region and likely be in conjunction with
multiple non-MHC loci with common alleles [16]. Since MHC
loci have been strongly associated with the development of
psoriasis, identification of non-MHC loci associated with psoriasis
may have been hindered by likely occurrence of genetic
heterogeneity [9]. In addition, a possible reason for the erratic
replications of genetic association findings could be that the large
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loci involved in psoriasis [5]. Therefore it is necessary to examine
the genetic loci associated with psoriasis conditioning on the effect
of the PSOR1 locus.
Because of the extensive LD existing between the SNPs within
MHC, identification of genetic variants to be associated with
human disease is a challenging task. Routine haplotype analysis
has a limited role in identifying independent SNPs in such a large
linkage disequilibrium block within MHC. Conditional analysis
approach adjusting for one top association signals from MHC
have been used to search for other independent associations under
an additive model [17,18,19]. Since a number of association
signals are often seen in the MHC region, selections of the top
associated SNP for a conditional analysis can vary, consequently
may lead to different results.
In this study, we have employed a sophisticated approach to
search for independent association signals within the MHC region.
We first determined the variable importance of each SNP in the
MHC region using both RandomForest algorithm and single SNP
association, and then used each of the most important SNPs as a
starting SNP to build a multiple regression model from more than
3,000 SNPs within the MHC. In the four regression models we
built, two loci in HLA-C/HLA-B and HLA-DQA2 consistently
appear in all models, and more importantly, rs9468925 in HLA-C/
HLA-B is reported as the top association signal in a GWAS of
vitiligo in the same population of study. Association analysis of
non-MHC loci while controlling for all SNPs in regression models
confirms that the association of psoriasis with the LCE gene cluster
previously identified through a GWAS, and indicates a number of
novel non-MHC loci to follow up for further study.
Materials and Methods
Study subjects
Study subjects comprised of psoriasis cases and healthy controls
recruited across China. Diagnosis, clinical assessment and
recruitment of participants have previously been described
elsewhere [11]. Briefly, the study subjects were recruited from
Chinese Han population through the collaboration by multiple
hospitals in China. The clinical diagnosis of all patients was
confirmed by at least two dermatologists. Clinical information on
patients was collected through a full clinical checkup, and
additional demographic information was also collected from both
patients and controls through face to face interview with a
structured questionnaire. All controls used in this study were
individuals who were confirmed without psoriasis, any autoim-
mune disorders, systemic disorders, and any family history
(including first-, second- and third-degree relatives) of psoriasis.
Cases and controls were matched by gender and age (within five
years). Cases were predominantly early onset patients. The total
number of subjects for the analysis includes 1,139 cases with
psoriasis and 1,132 controls.
The study was approved by the Ethical Review Board of Anhui
Medical University in accordance with the provisions of the
Declaration of Helsinki, and by the Institutional Review Board of
Anhui Medical University. Collection of blood samples and
clinical information from cases and controls was undertaken after
a written informed consent was obtained from all participants.
SNP genotyping
Genotyping has also been described in our previous study [11].
In brief, the genomic DNA was extracted using established
method. EDTA anticoagulated venous blood samples were
collected from all participants. The genomic DNA was extracted
from peripheral blood lymphocytes by standard procedures using
Flexi Gene DNA kits (Qiagen) and was diluted to the
concentration of 50 ng/ml for the genome-wide genotyping.
Samples were genotyped using Illumina Human 610-Quad
BeadChips (San Diego, USA). Genome-wide genotype data were
filtered sequentially using minor allele frequency.1%, genotyping
rate .95%, sample genotyping rate .98% and HWE test p value
,0.00001 in the control cohort. After genome-wide quality
control of genotype, 3,033 SNPs within a 3.6 Mb of MHC region
were included for analysis.
Statistical analysis
The variable importance was first assessed for all SNPs in the
MHC. Traditionally, variable importance of a SNP is determined
by p value from single SNP association test, which is based on a
statistics of relative measure of estimated coefficient and its
standard error. In genetic association study, p value usually
measures the linear (or log-linear) relationship between SNP and
an outcome of disease. However, the association p value may not
measure the importance of a SNP that has both association and
possible interactions with other SNPs. Therefore we also applied
RandomForest algorithm to determine the variable importance of
each SNP in the MHC region [20,21].
The most important SNPs were selected as starting SNPs to
build multiple regression models using stepwise logistic regression.
Multiple regression analysis is more powerful in establishing more
robust association than single SNP association analysis, because it
controls for potential genetic heterogeneity, confounding factors
and population stratification [22,23]. Stepwise regression is an
automated procedure that is normally used to select independent
variables to build a multiple regression model from a large number
of variables. We coded each SNP as a categorical variable (0, 1
and 2). Stepwise logistic regression analysis was performed while
controlling for sex, sample geographic location and one of most
important SNPs according to both RandomForest analysis and
single SNP association. We used the level of 0.05 for entering a
SNP, and 0.1 for a SNP being removed from a model. Predicted
probability of being in disease group was estimated for each of
final logistic regression models, and was used as a covariate for
genome-wide association analysis of non-MHC SNPs. The
analysis was performed using SAS and Random Forest in R
package (http://www.r-project.org/).
Results
Total 1,139 cases with psoriasis and 1,132 normal controls were
included in the analysis (Table 1). The ratio of male to female in
the study subjects was matched well between cases (669/470) and
controls (670/462). The mean age in cases was 30.98 years
roughly matched 35.09 years in controls. In the previous GWAS,
we have confirmed strong association signals at rs1265181 in the
MHC region and, rs3213094 in IL12B, and identified several
novel susceptible loci in the LCE gene cluster on 1q21.
Eight SNPs were found to be the most important in the MHC
region using the RandomForest algorithm (Figure S1). These
included rs130065, rs720465 and rs3130455 in CCHCR1,
rs1265159 and rs3130457 in POU5F1, rs1265181 in HCG27,
and rs2248902 and rs10484554 in HLA-C/HLA-B. Almost all of
them were located within the PSOR1 locus and appeared to be in
strong LD. The variable importance of SNPs determined through
RandomForest algorithm was largely consistent with single SNP
association results (Table S1). This is expected because the SNPs
in the PSOR1 locus tend to have a strong main-effect. Finally
SNPs rs130065 (CCHCR1), rs3130457 (POU5F1), rs1265181
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starting SNP to build a multiple regression model (Figure 1). Also
these SNPs have previously been associated with psoriasis.
SNPs selected into the multiple regression models were identical
between Model 1 and Model 2 except the starting SNPs (Table 2).
When rs1265181 in HCG27 was controlled (Model 1), four SNPs
including rs9468925 in HLA-C/HLA-B, rs2442719 in HLA-B,
rs4947324 in NFKBIL1 and rs2858881 in HLA-DQA2 were
selected. While rs130065 in CCHCR1 was controlled (Model2),
the exact same four SNPs were selected, and the effect size for
each SNP was very close between two models. As it is expected,
both rs1265181 and rs130065 showed much stronger effects than
others on the risk of psoriasis in the regression models. We also
performed functional prediction of SNPs that were selected into
the multiple regression models. Only rs130065 appeared to be
non-synonymous, and was found to have regulation potential
(prediction score=0.501) and likely conserved in multiple species
(prediction score=0.348). According to the analysis of genotype
data in this study, rs130065 (r
2=0.93, D9=0.99) and rs1265181
(r
2=0.99, D9=1) are highly correlated with rs3130457, a SNP in
POU5F1 that is completely tagged to the classical HLA-C*0602
allele that has been consistently associated with psoriasis in
multiple populations.
Majority of SNPs selected in Model 3 (POU5F1) and Model 4
(HLA-C) was similar (Table 2). SNPs rs9257843 in OR12D2,
rs9257843 in IER3, rs9468925 in HLA-C/HLA-B, rs7770216 in
LOC729816, rs2251396, rs2523454 and rs12175498 in MICA,
rs511027 in NOTCH4, rs2858881 in HLA-DQA2 and rs9368758 in
COL11A2 appear to be significant in Model 3. In addition to the
same set of SNPs, two additional SNPs–rs7760698 in POU5F1 and
rs1265181 in HCG27 were selected into Model 4. The starting
SNP rs3130457 at POU5F1 completely tags to the classical HLA-
C*0602 in Han Chinese, and it is in strong LD with another
starting SNP rs10484554 (r
2=0.9, D9=0.982) in HLA-C.I ti s
worth noting that rs1265181 in HCG27 selected into Model 4 with
HLA-C, also showed the strongest association in Model 1.
Very interestingly, two common SNPs in HLA-C/HLA-B and
HLA-DQA2 were selected by the entire four regression models
(Table 1, Figure 2). Minor allele at rs9468925 in HLA-C/HLA-B
appear to be negatively associated with psoriasis in all four models
(OR=0.53–0.65, P=1.22e-08 to 1.70e-05). SNP rs9468925 was
Table 1. Summary demographics of study sujects.
CASES CONTROLS
sample size 1139 1132
mean age 30.98 years 35.09 years
SD 12.31 years 13.2 years
Male 669 670
Female 470 462
doi:10.1371/journal.pone.0023089.t001
Figure 1. Recombination rates and p values from single SNP associations at four starting SNPs and rs9468925 in HLA-C/HLA-B
appeared in four models, based on combined Japanese and Han Chinese sample in HapHap data(JPT+CHB) and is not in LD with all
of four starting SNPs.
doi:10.1371/journal.pone.0023089.g001
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SNPs for building multiple regression models, and neither in LD
with the HLA-C*0602 allele (r
2=0.177) in Han Chinese
(Figure 1). SNP rs2858881 in HLA-DQA2 (OR=1.72 to1.98,
P=1.08e-03 to 1.18e-2) were also consistently included in all
regression models (Table 1), while it is not significant in single
SNP association in previous GWAS of psoriasis.
A number of non-MHC loci appeared to be significantly
associated with psoriasis while the MHC locus was controlled
(Table S2). The most significant association of non-MHC SNPs
with psoriasis were observed at four SNPs in LCE3A and LCE3D in
the LCE gene cluster (p,5e-06), which is consistent with previous
findings from GWAS [11]. Fifty-six SNPs in 39 genes were
associated with psoriasis. Fifteen out of thirty-nine genes were
Table 2. Multiple logistic regression models of MHC Loci.
Association in
GWAS Multiple logistic regerssion model
Genename SNPID SNP BP A1 F_A F_U A2 P OR 95% CI P_add P_geno
Model 1
HCG27* 1344 rs1265181 31263764 G 0.46 0.10 C 5.8E-159 14.04 10.79 18.27 5.65E-86 2.70E-82
HLA-C 1442 rs9468925 31366816 A 0.21 0.41 G 9.3E-50 0.65 0.54 0.79 1.70E-05 1.14E-05 **
HLA-B 1499 rs2442719 31428517 A 0.64 0.34 G 3.0E-92 1.61 1.30 2.01 1.66E-05 5.58E-06
NFKBIL1 1752 rs4947324 31636109 T 0.13 0.05 C 1.3E-21 2.20 1.62 2.99 4.83E-07 8.85E-05
HLA-DQA2 2476 rs2858881 32811823 G 0.04 0.04 A 7.3E-01 1.91 1.27 2.89 2.08E-03 7.42E-03 **
Model2
CCHCR1* 1301 rs130065 31230479 T 0.48 0.11 C 9.6E-170 11.22 8.73 14.43 2.65E-79 4.86E-82
HLA-C 1442 rs9468925 31366816 A 0.21 0.41 G 9.3E-50 0.62 0.51 0.75 1.13E-06 2.40E-05 **
HLA-B 1499 rs2442719 31428517 A 0.64 0.34 G 3.0E-92 1.65 1.33 2.05 5.28E-06 3.24E-05
NFKBIL1 1752 rs4947324 31636109 T 0.13 0.05 C 1.3E-21 2.15 1.59 2.91 7.01E-07 9.54E-06
HLA-DQA2 2476 rs2858881 32811823 G 0.04 0.04 A 7.3E-01 1.72 1.13 2.63 1.18E-02 5.23E-03 **
Model 3
OR12D2 49 rs9257843 29476644 C 0.49 0.38 T 8.7E-13 1.34 1.13 1.58 7.10E-04 5.54E-04
IER3 912 rs9262176 30839309 T 0.02 0.01 C 8.1E-02 2.76 1.41 5.38 2.99E-03 1.99E-03
POU5F1* 1328 rs1265159 31248026 T 0.46 0.10 C 1.2E-156 24.31 18.47 32.00 1.26E-114 2.39E-109
HLA-C 1442 rs9468925 31366816 A 0.21 0.41 G 9.3E-50 0.53 0.43 0.66 1.22E-08 7.75E-08 **
LOC729816 1522 rs7770216 31448590 T 0.36 0.39 G 5.1E-02 1.90 1.53 2.37 9.01E-09 8.82E-08
MICA 1554 rs2251396 31472686 T 0.15 0.25 C 1.1E-18 0.24 0.16 0.37 7.62E-11 2.53E-10
MICA 1556 rs2523454 31475844 T 0.20 0.28 C 8.3E-12 3.28 2.04 5.29 1.03E-06 5.86E-07
MICA 1566 rs12175489 31485566 A 0.19 0.31 G 6.0E-20 0.59 0.43 0.82 1.36E-03 2.87E-04
NOTCH4 2080 rs511027 32314665 A 0.06 0.08 T 6.9E-03 1.52 1.09 2.14 1.49E-02 1.82E-04
HLA-DQA2 2476 rs2858881 32811823 G 0.04 0.04 A 7.3E-01 1.81 1.21 2.71 3.66E-03 1.53E-03 **
COL11A2 2922 rs9368758 33245999 A 0.47 0.51 G 5.9E-03 1.33 1.11 1.59 1.71E-03 1.25E-03
Model 4
OR12D2 49 rs9257843 29476644 C 0.49 0.38 T 8.7E-13 1.29 1.09 1.53 3.26E-03 2.10E-03
IER3 912 rs9262176 30839309 T 0.02 0.01 C 8.1E-02 3.11 1.57 6.16 1.12E-03 9.98E-04
POU5F1 1340 rs7760698 31258204 A 0.01 0.02 T 1.2E-01 0.23 0.09 0.59 1.93E-03 2.76E-03
HCG27 1344 rs1265181 31263764 G 0.46 0.10 C 5.8E-159 4.68 2.13 10.31 1.28E-04 6.19E-07
HLA-C 1442 rs9468925 31366816 A 0.21 0.41 G 9.3E-50 0.58 0.47 0.73 2.03E-06 9.03E-06 **
HLA-C* 1483 rs10484554 31382534 T 0.48 0.11 C 5.5E-158 6.35 2.87 14.06 5.12E-06 3.20E-05
LOC729816 1522 rs7770216 31448590 T 0.36 0.39 G 5.1E-02 1.74 1.40 2.17 8.61E-07 6.79E-06
MICA 1554 rs2251396 31472686 T 0.15 0.25 C 1.1E-18 0.24 0.16 0.37 1.18E-10 2.61E-10
MICA 1556 rs2523454 31475844 T 0.20 0.28 C 8.3E-12 3.84 2.36 6.23 5.49E-08 7.01E-08
MICA 1566 rs12175489 31485566 A 0.19 0.31 G 6.0E-20 0.62 0.45 0.86 4.20E-03 2.35E-03
NOTCH4 2080 rs511027 32314665 A 0.06 0.08 T 6.9E-03 1.47 1.05 2.08 2.66E-02 2.27E-04
HLA-DQA2 2476 rs2858881 32811823 G 0.04 0.04 A 7.3E-01 1.98 1.31 2.98 1.08E-03 3.45E-04 **
COL11A2 2922 rs9368758 33245999 A 0.47 0.51 G 5.9E-03 1.36 1.13 1.62 9.52E-04 1.67E-03
Note:
**are SNPs consistently appeared in 4 models; highlighted are starting SNPs in each model; sex and sample region were controlled in each model; the first SNPs forced
to be in the model.
doi:10.1371/journal.pone.0023089.t002
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interaction, and other fifteen genes were unknown for their
functions.
Discussion
We have examined the association of SNPs in the MHC region
with psoriasis using multiple regression models. When the top
associated SNPs in PSOR1 locus were controlled, stepwise logistic
regressionsof3,033SNPsfromthe MHCregionlargelyshowedtwo
sets of markers (Model 1, 2 vs Model 3, 4) associated with psoriasis,
although starting four SNPs (rs130065, rs3130457, rs1265181 and
rs10484554) are in strong LD. SNP rs9468925 in HLA-C/HLA-B
consistently appears in all four regression models, indicating that an
independent HLA locus is associated with psoriasis. It is interesting
to see that rs9468925 is also the top associated SNP in a recent
GWAS in Han Chinese population with vitiligo, another major skin
disorderwith autoimmunecomponents[24].Wehaveprovidedone
important evidence for that psoriasis shares the common genetic
variants with vitiligo, and the effect size is similar (OR=0.65 in
psoriasis vs. OR=0.75 in vitiligo).
When top SNPs rs1265181 in HCG27 or rs130065 in CCHCR1
is controlled, the same set of SNPs from HLA-B, HLA-C/HLA-B,
HLA-DQA2 and NFKBIL1 are selected. This is expected because
two SNPs are in strong LD (r2=0.935, D9=0.998) and both are
good approximate to HLA-C*0602, known to be associated with
psoriasis. SNP rs1265181 in HCG27 is the top association signals
in a GWAS of psoriasis in Han Chinese population [11], while
rs130065 in CCHCR1 has been consistently associated with
psoriasis in multiple populations [25,26,27], and HCR1 protein
expressed differently between lesional skin and normal skin [26].
CCHCR1 may function as a negative regulator of keratinocyte
proliferation; aberrant function of CCHCR1 may lead to abnormal
keratinocyte proliferation which is a key feature of psoriatic
epidermis [28]. However, other studies show that the association
may be due to the strong linkage disequilibrium with HLA-C*0602,
and it is difficult to distinguish the genetic association of CCHCR1
from HLA-C*0602, which is completely tagged by a single SNP
(rs3130457, Allele A) in Han Chinese population [29].
While HLA-C*0602 (approximate to rs130065 and tagged by
rs3130457) is controlled, multiple regression analysis of SNPs in
the MHC loci reveal independent associations of additional both
Figure 2. Venn diagram of SNPs selected in four models. Intersection indicates shared SNPs selected from different models.
doi:10.1371/journal.pone.0023089.g002
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HLA-DQA2, functioned as antigen presentation and likely
expressed in human B lymphoblastoid cell lines [30,31], has been
associated with autoimmune disorders such as type 1 diabetes,
rheumatoid arthritis and alopecia areata [32,33]. NFKBIL1, a non-
HLA gene, encodes a divergent member of the I-kappa-B family of
proteins, critical components of the NF-kB signaling pathway. It
regulates the transcription of many important mediators of
inflammation and tissue destruction in the psoriasis including
TNF, IL-1 and IL-6. NFKBIL1 has also been associated with
autoimmune disorders such as rheumatoid arthritis, SLE and
Sjogren’s syndrome [34,35]. This suggests that in addition to
genetic variants that regulate keratinocyte proliferation, genes
involved with autoimmune diseases likely contribute to the risk of
psoriasis, supporting that psoriasis has autoimmune components.
We have also found that rs2442719 in HLA-B is associated
psoriasis. This is consistently with the previous analysis, condi-
tioning PSOR1 locus (HLA-C*0602) in both Chinese and
European ancestry population [18].
Two similar regression models were built when SNPs rs3130457
in POU5F1 and rs10484554 in HLA-C were controlled. Although
two models selected different sets of SNPs from previous ones
when SNPs in HCG27 and CCHCR1 were controlled, SNPs
rs9468925 in HLA-C/HLA-B and rs2858881 in HLA-DQA2 were
repeatedly selected, providing robust evidence for that association
of these two classical HLA loci with the development of psoriasis.
SNP rs3130457 in POU5F1 tags the classical HLA-C*0602 allele,
while rs10484554 in HLA-C is the most significant SNP associated
with psoriasis and psoriatic arthritis in European ancestry
population [36]. It is interesting to note that rs3130457 in
POU5F1 is in strong LD with rs1265181 in HCG27 and rs130065
in CCHCR1, but two different models were built. In addition, we
found that SNPs from several non-HLA genes including
rs2251396, rs2523454 and rs12175589 in MICA, rs7770216 in
LOC729816, rs511027 in NOTCH4, rs9257483 in OR12D2 and
9262167 in IER3 were associated with psoriasis in multiple
regression analyses. Except that rs7770216 in LOC729816 has
been reported to significantly interact with rs563495 on rheuma-
toid arthritis [37], and rs2251396 has been tagged to classical
HLA-B*04601 allele in Japanese population, all others non-HLA
loci appear to be novel loci for psoriasis.
Although these non-HLA loci in the MHC region are
statistically less significant than compared to the HLA loci, they
may shed a light on additional components of pathogenesis in
psoriasis. All of these non-HLA genes such as POU5F1, MICA,
NOTCH4, IER3 and OR12D2 are coding for proteins. POU5F1 is a
transcription factor and encodes a key regulator of stem cell
pluripotency, and has been noted as one of four genes having stem
cell potential and being expressed in embryonic stem cells and
tumor cells [38]. POU5F1 is likely to play a role in epithelial
tumors such as skin and salivary glands [39,40]. Previous studies
have shown that a genetic polymorphism of POU5F1 is associated
with psoriasis in Chinese population [41]. A stronger association
than HLA-C*0602, in particular in HLA-C*0602 negative individ-
uals, is observed with psoriasis in Spanish population [42]. MICA is
expressed on the cell surface, and functions as a stress-induced
antigen that is broadly recognized by intestinal epithelial gamma
delta T cells. Although MICA is strongly in LD with HLA-B, it has
been associated with psoriasis and evidenced for an association
independently of HLA-B/C with psoriatic arthritis in Jewish
population [43,44]. NOTCH4 encodes a member of the Notch
family that play a role in a variety of developmental processes by
controlling cell fate decisions. NOTCH4 has been predominantly
associated with neuropsychiatric disorders [45,46]; little informa-
tion is available on the association with psoriasis. IER3, an early
response gene that is induced by ionizing and ultraviolet radiation,
is widely expressed in epithelial and endocrine tissues and the
expression is regulated by multiple transcriptional factors such as
NF-kappaB/rel, p53 and c-Myc [47,48,49]. It accelerates cell cycle
progression and supports the survival of T cells, causing
autoimmune disease and the development of T cell lymphoma.
OR12D2, olfactory receptors interact with odorant molecules in
the nose to initiate a neuronal response that triggers the perception
of a smell. Defects in COL11A2 are the cause of deafness autosomal
dominant type 13 (DFNA13), form of sensorneural hearing loss,
which results from damage to the neural receptors of the inner ear,
the nerve pathways to the brain.
Our study may have some important implications for searching
for genetic variants associated with complex human disorders.
Primary nature of psoriasis is as an epithelial and immunological
disorder with autoimmune cause of inflammatory process. Genetic
components of both immune system and the epidermis contribute
to the disease [50]. Previous single SNP-phenotype analysis may
not reflect the nature of parthenogenesis of the disease. Multiple
regression analysis allows us to examine how multiple relatively
independent genes together contribute to the risk of disease. It is
believed that environmental factors play a certain role in the
development of psoriasis. Identification of genetic association in
those environmental response genes may help to elucidate the
molecular mechanism of the disease.
In summary, through multiple regression analysis of SNPs in
MHC loci, we found SNPs in classical HLA gene shared between
two major skin disorders–psoriasis and vitiligo. In addition to
classical HLA genes such as HLA-C, HLA-B and HLA-DQA2,w e
also find association of non-HLA genes in the MHC region such as
POU5F1, NFKBIL1, NOTCH4, MICA, IER3 and OR12D2 with
psoriasis. Our analysis may provide the first genetic evidence that
psoriasis is involved with multiple independent components of
immune response, inflammation, skin keratinization and prolifer-
ation, autoimmune and stress-related pathways. This multimarker
analysis may provide a basis for the disease-prediction based on
genetic variants associated with the disease.
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